109 related articles for article (PubMed ID: 2184237)
1. Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease.
Rich DH; Green J; Toth MV; Marshall GR; Kent SB
J Med Chem; 1990 May; 33(5):1285-8. PubMed ID: 2184237
[No Abstract] [Full Text] [Related]
2. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
Margolin N; Heath W; Osborne E; Lai M; Vlahos C
Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
[TBL] [Abstract][Full Text] [Related]
3. Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.
Copeland TD; Wondrak EM; Tozser J; Roberts MM; Oroszlan S
Biochem Biophys Res Commun; 1990 May; 169(1):310-4. PubMed ID: 2190554
[TBL] [Abstract][Full Text] [Related]
4. Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
Richards AD; Phylip LH; Farmerie WG; Scarborough PE; Alvarez A; Dunn BM; Hirel PH; Konvalinka J; Strop P; Pavlickova L
J Biol Chem; 1990 May; 265(14):7733-6. PubMed ID: 2186027
[TBL] [Abstract][Full Text] [Related]
5. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.
Phylip LH; Richards AD; Kay J; Kovalinka J; Strop P; Blaha I; Velek J; Kostka V; Ritchie AJ; Broadhurst AV
Biochem Biophys Res Commun; 1990 Aug; 171(1):439-44. PubMed ID: 2203349
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of HIV-1 proteinase by cerulenin.
Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH
FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152
[TBL] [Abstract][Full Text] [Related]
7. Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus.
Grobelny D; Wondrak EM; Galardy RE; Oroszlan S
Biochem Biophys Res Commun; 1990 Jun; 169(3):1111-6. PubMed ID: 2114105
[TBL] [Abstract][Full Text] [Related]
8. Rational design of peptide-based HIV proteinase inhibitors.
Roberts NA; Martin JA; Kinchington D; Broadhurst AV; Craig JC; Duncan IB; Galpin SA; Handa BK; Kay J; Kröhn A
Science; 1990 Apr; 248(4953):358-61. PubMed ID: 2183354
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein.
Shoeman RL; Höner B; Stoller TJ; Kesselmeier C; Miedel MC; Traub P; Graves MC
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6336-40. PubMed ID: 2201025
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.
Dreyer GB; Metcalf BW; Tomaszek TA; Carr TJ; Chandler AC; Hyland L; Fakhoury SA; Magaard VW; Moore ML; Strickler JE
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9752-6. PubMed ID: 2690072
[TBL] [Abstract][Full Text] [Related]
11. Identification of a human immunodeficiency virus-1 protease cleavage site within the 66,000 Dalton subunit of reverse transcriptase.
Graves MC; Meidel MC; Pan YC; Manneberg M; Lahm HW; Grüninger-Leitch F
Biochem Biophys Res Commun; 1990 Apr; 168(1):30-6. PubMed ID: 1691640
[TBL] [Abstract][Full Text] [Related]
12. Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.
Erickson J; Neidhart DJ; VanDrie J; Kempf DJ; Wang XC; Norbeck DW; Plattner JJ; Rittenhouse JW; Turon M; Wideburg N
Science; 1990 Aug; 249(4968):527-33. PubMed ID: 2200122
[TBL] [Abstract][Full Text] [Related]
13. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
Matayoshi ED; Wang GT; Krafft GA; Erickson J
Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
[TBL] [Abstract][Full Text] [Related]
14. Peptide substrates and inhibitors of the HIV-1 protease.
Moore ML; Bryan WM; Fakhoury SA; Magaard VW; Huffman WF; Dayton BD; Meek TD; Hyland L; Dreyer GB; Metcalf BW
Biochem Biophys Res Commun; 1989 Mar; 159(2):420-5. PubMed ID: 2649094
[TBL] [Abstract][Full Text] [Related]
15. Subsite preferences of retroviral proteinases.
Dunn BM; Gustchina A; Wlodawer A; Kay J
Methods Enzymol; 1994; 241():254-78. PubMed ID: 7854181
[No Abstract] [Full Text] [Related]
16. Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution.
Fitzgerald PM; McKeever BM; VanMiddlesworth JF; Springer JP; Heimbach JC; Leu CT; Herber WK; Dixon RA; Darke PL
J Biol Chem; 1990 Aug; 265(24):14209-19. PubMed ID: 2201682
[TBL] [Abstract][Full Text] [Related]
17. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
[TBL] [Abstract][Full Text] [Related]
19. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
McQuade TJ; Tomasselli AG; Liu L; Karacostas V; Moss B; Sawyer TK; Heinrikson RL; Tarpley WG
Science; 1990 Jan; 247(4941):454-6. PubMed ID: 2405486
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
